LENZ Therapeutics (LENZ) Stock: Why It Rose
Updated Oct 19, 2026, 4:00 PM ET · closing price
- Closed at $3.30, +0.92% vs the prior close of $3.27.
- Volume 648.70K shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)
LENZ rises 0.9% to $3.30. Closed at $3.30, +0.92% vs the prior close of $3.27. Day range $3.21–$3.40, opened at $3.27.
LENZ daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — LENZ rises 0.9% to $3.30
- Closed at $3.30, +0.92% vs the prior close of $3.27. Day range $3.21–$3.40, opened at $3.27.
- Volume was 648.74K shares, 0.9x its 50-day average of 748.79K.
- Price is -24.5% vs its 50-day average ($4.37) and -61.7% vs its 200-day average ($8.61).
- 52-week range $3.21–$39.94; today's close sits at 0% of that range, 91.7% below the 52-week high.
Oct 16, 2026 — LENZ slides 8.4% to $3.27, a 52-week low
- Closed at $3.27, -8.40% vs the prior close of $3.57. Day range $3.21–$3.56, opened at $3.56.
- Volume was 938.85K shares, 1.3x its 50-day average of 740.72K.
- Price is -25.9% vs its 50-day average ($4.41) and -62.3% vs its 200-day average ($8.67).
- 52-week range $3.21–$42.98; today's close sits at 0% of that range, 92.4% below the 52-week high.
Oct 15, 2026 — LENZ jumps 4.1% to $3.57
- Closed at $3.57, +4.08% vs the prior close of $3.43. Day range $3.43–$3.64, opened at $3.43.
- Volume was 793.80K shares, 1.1x its 50-day average of 744.13K.
- Price is -19.8% vs its 50-day average ($4.45) and -59.1% vs its 200-day average ($8.74).
- 52-week range $3.35–$42.98; today's close sits at 1% of that range, 91.7% below the 52-week high.
Oct 14, 2026 — LENZ rises 0.9% to $3.43
- Closed at $3.43, +0.88% vs the prior close of $3.40. Day range $3.35–$3.62, opened at $3.39.
- Volume was 1.04M shares, 1.4x its 50-day average of 740.23K.
- Price is -23.6% vs its 50-day average ($4.49) and -61.0% vs its 200-day average ($8.80).
- 52-week range $3.35–$42.98; today's close sits at 0% of that range, 92.0% below the 52-week high.
Oct 13, 2026 — LENZ slides 5.8% to $3.40, a 52-week low
- Closed at $3.40, -5.82% vs the prior close of $3.61. Day range $3.39–$3.62, opened at $3.62.
- Volume was 602.00K shares, 0.8x its 50-day average of 748.80K.
- Price is -24.8% vs its 50-day average ($4.52) and -61.7% vs its 200-day average ($8.87).
- 52-week range $3.35–$42.98; today's close sits at 0% of that range, 92.1% below the 52-week high.
Oct 12, 2026 — LENZ dips 1.0% to $3.61
- Closed at $3.61, -0.96% vs the prior close of $3.64. Day range $3.60–$3.71, opened at $3.64.
- Volume was 603.50K shares, 0.8x its 50-day average of 754.03K.
- Price is -20.7% vs its 50-day average ($4.55) and -59.6% vs its 200-day average ($8.94).
- 52-week range $3.35–$46.75; today's close sits at 1% of that range, 92.3% below the 52-week high.
Oct 9, 2026 — LENZ jumps 3.3% to $3.64
- Closed at $3.64, +3.26% vs the prior close of $3.53. Day range $3.42–$3.65, opened at $3.53.
- Volume was 625.60K shares, 0.8x its 50-day average of 751.28K.
- Price is -20.5% vs its 50-day average ($4.59) and -59.5% vs its 200-day average ($9.00).
- 52-week range $3.35–$49.16; today's close sits at 1% of that range, 92.6% below the 52-week high.
Oct 8, 2026 — LENZ dips 2.5% to $3.53, a 52-week low
- Closed at $3.53, -2.49% vs the prior close of $3.62. Day range $3.35–$3.61, opened at $3.58.
- Volume was 1.04M shares, 1.4x its 50-day average of 744.99K.
- Price is -23.7% vs its 50-day average ($4.63) and -61.1% vs its 200-day average ($9.07).
- 52-week range $3.35–$49.25; today's close sits at 0% of that range, 92.8% below the 52-week high.
Oct 7, 2026 — LENZ slides 4.5% to $3.62
- Closed at $3.62, -4.49% vs the prior close of $3.79. Day range $3.58–$3.72, opened at $3.72.
- Volume was 515.20K shares, 0.7x its 50-day average of 747.47K.
- Price is -22.5% vs its 50-day average ($4.67) and -60.4% vs its 200-day average ($9.14).
- 52-week range $3.45–$49.25; today's close sits at 0% of that range, 92.6% below the 52-week high.
Oct 6, 2026 — LENZ jumps 5.6% to $3.79
- Closed at $3.79, +5.57% vs the prior close of $3.59. Day range $3.60–$3.84, opened at $3.60.
- Volume was 682.80K shares, 0.9x its 50-day average of 757.44K.
- Price is -19.6% vs its 50-day average ($4.72) and -58.9% vs its 200-day average ($9.21).
- 52-week range $3.45–$49.25; today's close sits at 1% of that range, 92.3% below the 52-week high.
Oct 5, 2026 — LENZ ends flat (+0.3%) to $3.59
- Closed at $3.59, +0.28% vs the prior close of $3.58. Day range $3.45–$3.60, opened at $3.60.
- Volume was 777.40K shares, 1.0x its 50-day average of 770.48K.
- Price is -24.5% vs its 50-day average ($4.75) and -61.3% vs its 200-day average ($9.27).
- 52-week range $3.45–$49.85; today's close sits at 0% of that range, 92.8% below the 52-week high.
Oct 2, 2026 — LENZ slides 5.5% to $3.58, a 52-week low, 4 down days in a row
- Closed at $3.58, -5.54% vs the prior close of $3.79. Day range $3.51–$3.84, opened at $3.84.
- Volume was 1.13M shares, 1.5x its 50-day average of 760.22K.
- Price is -25.3% vs its 50-day average ($4.79) and -61.7% vs its 200-day average ($9.34).
- 52-week range $3.51–$50.40; today's close sits at 0% of that range, 92.9% below the 52-week high.
- That makes 4 straight losses.
LENZ bull case vs bear case (from the data)
- Insiders made 17 open-market purchases in the last 12 months.
- Price is -24.5% vs its 50-day average — short-term trend is down.
- Price is -61.7% vs its 200-day average — below the long-term trend line.
- Latest fiscal-year net income: loss of $82.13M.
- Share count up 10.2% in a year (dilution).
- High volatility: average daily move of 3.2% over 20 sessions.
LENZ latest news & SEC filings
Every SEC filing by or about LENZ in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 8, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 11, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $5.49M (prior year $5.00M) (+9.7% vs Jun 30, 2025)
- Net income: -$31.92M (prior year -$14.91M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$1.02 (prior year -$0.53) (loss widened vs Jun 30, 2025)
Aug 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Jun 26, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade LENZ
- Last results release: Aug 11, 2026 (8-K Item 2.02). Previous ones: May 11, 2026, Mar 24, 2026, Jan 7, 2026. Based on that rhythm, the next report is likely around Nov 10, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.23% (largest 9.0%). That is a volatile stock.
- Liquidity: about 773.77K shares (≈$2.55M) trade per day on average.
- 52-week position: $3.30 vs a range of $3.21–$39.94 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 17 open-market buys, 8 sales; latest: Jeffrey P. George bought 5,592 shares on Mar 27, 2026.
- Latest filings: 10-Q Aug 11, 2026; 8-K Aug 11, 2026; 8-K Jul 2, 2026.
- Share count: 31.42M shares outstanding (Aug 5, 2026), +10.2% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
LENZ market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 3.27 | 3.40 | 3.21 | 3.30 | 648.70K |
| Oct 16, 2026 | 3.56 | 3.56 | 3.21 | 3.27 | 938.90K |
| Oct 15, 2026 | 3.43 | 3.64 | 3.43 | 3.57 | 793.80K |
| Oct 14, 2026 | 3.39 | 3.62 | 3.35 | 3.43 | 1.04M |
| Oct 13, 2026 | 3.62 | 3.62 | 3.39 | 3.40 | 602.00K |
| Oct 12, 2026 | 3.64 | 3.71 | 3.60 | 3.61 | 603.50K |
| Oct 9, 2026 | 3.53 | 3.65 | 3.42 | 3.64 | 625.60K |
| Oct 8, 2026 | 3.58 | 3.61 | 3.35 | 3.53 | 1.04M |
| Oct 7, 2026 | 3.72 | 3.72 | 3.58 | 3.62 | 515.20K |
| Oct 6, 2026 | 3.60 | 3.84 | 3.60 | 3.79 | 682.80K |
| Oct 5, 2026 | 3.60 | 3.60 | 3.45 | 3.59 | 777.40K |
| Oct 2, 2026 | 3.84 | 3.84 | 3.51 | 3.58 | 1.13M |
| Oct 1, 2026 | 3.85 | 3.91 | 3.79 | 3.79 | 738.90K |
| Sep 30, 2026 | 3.90 | 3.90 | 3.75 | 3.84 | 786.20K |
| Sep 29, 2026 | 3.96 | 3.97 | 3.79 | 3.86 | 644.90K |
| Sep 28, 2026 | 3.89 | 3.99 | 3.68 | 3.96 | 711.80K |
| Sep 25, 2026 | 3.75 | 4.00 | 3.66 | 3.91 | 923.80K |
| Sep 24, 2026 | 3.75 | 3.75 | 3.60 | 3.72 | 1.01M |
| Sep 23, 2026 | 4.14 | 4.14 | 3.73 | 3.76 | 761.00K |
| Sep 22, 2026 | 4.10 | 4.18 | 4.07 | 4.13 | 510.50K |
About LENZ Therapeutics
LENZ Therapeutics (LENZ) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in SOLANA BEACH, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1815776.
LENZ board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Kimberlee C Drapkin | Director | Jun 15, 2026 |
| Jeffrey P. George | Director | Jun 15, 2026 |
| Frederic Guerard | Director | Jun 15, 2026 |
| Peter Kolchinsky | Director | Jun 15, 2026 |
| James W Mccollum | Director | Jun 15, 2026 |
| Capital Management, L.P. Ra | Director | Jun 15, 2026 |
| Capital Healthcare Fund Lp Ra | Director | Jun 15, 2026 |
| Capital Nexus Fund Ii, L.P. Ra | Director | Jun 15, 2026 |
| Zachary Scheiner | Director | Jun 15, 2026 |
| Evert B. Schimmelpennink | President, CEO and Secretary | Mar 30, 2026 |
| Rajeev M. Shah | Director | Jun 15, 2026 |
| Shelley B Thunen | Director | Jun 15, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Daniel R. Chevallard | Chief Financial Officer | Mar 30, 2026 |
| Marc Odrich | Chief Medical Officer | Jan 6, 2026 |
| Shawn Olsson | Chief Commercial Officer | Jan 6, 2026 |
| Evert B. Schimmelpennink | President, CEO and Secretary | Mar 30, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Mar 27, 2026 | Jeffrey P. George | Buy | 5,592 | $8.92 |
| Mar 27, 2026 | Jeffrey P. George | Buy | 5,592 | $8.92 |
| Mar 27, 2026 | Jeffrey P. George | Buy | 5,592 | $8.92 |
| Mar 27, 2026 | Jeffrey P. George | Buy | 5,592 | $8.92 |
| Mar 27, 2026 | Daniel R. Chevallard | Buy | 7,500 | $8.57 |
| Mar 27, 2026 | Daniel R. Chevallard | Buy | 7,500 | $8.57 |
| Mar 27, 2026 | Daniel R. Chevallard | Buy | 7,500 | $8.57 |
| Mar 27, 2026 | Daniel R. Chevallard | Buy | 7,500 | $8.57 |
| Mar 27, 2026 | Evert B. Schimmelpennink | Buy | 28,089 | $8.95 |
| Mar 27, 2026 | Evert B. Schimmelpennink | Buy | 28,089 | $8.95 |
| Mar 27, 2026 | Evert B. Schimmelpennink | Buy | 28,089 | $8.95 |
| Mar 27, 2026 | Evert B. Schimmelpennink | Buy | 28,089 | $8.95 |
| Nov 17, 2025 | Shawn Olsson | Sale | 4,212 | $25.74 |
| Nov 17, 2025 | Shawn Olsson | Sale | 5,788 | $26.37 |
| Nov 17, 2025 | Shawn Olsson | Sale | 4,212 | $25.74 |
LENZ financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $19.09M | $-82.13M | -2.85 | $-69.17M |
| Dec 31, 2024 | $0 | $-49.77M | -2.34 | $-59.39M |
| Dec 31, 2023 | — | $-69.97M | -35.71 | $-60.38M |
| Dec 31, 2022 | — | $-101.05M | -1.84 | $-87.98M |
| Dec 31, 2021 | — | $-70.76M | -2.45 | $-52.85M |
Latest balance sheet: total assets $236.60M, total liabilities $17.33M, cash $24.21M (as of Jun 30, 2026).
LENZ earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 11, 2026 | 8-K Item 2.02 (results) | $5.21 |
| May 11, 2026 | 8-K Item 2.02 (results) | $9.99 |
| Mar 24, 2026 | 8-K Item 2.02 (results) | $9.03 |
| Jan 7, 2026 | 8-K Item 2.02 (results) | $16.31 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $21.47 |
| Jul 30, 2025 | 8-K Item 2.02 (results) | $30.76 |
| May 7, 2025 | 8-K Item 2.02 (results) | $25.34 |
| Apr 15, 2025 | 8-K Item 2.02 (results) | $23.89 |
| Mar 19, 2025 | 8-K Item 2.02 (results) | $25.52 |
| Nov 6, 2024 | 8-K Item 2.02 (results) | $32.23 |
| Aug 14, 2024 | 8-K Item 2.02 (results) | — |
| May 8, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Biogen (BIIB)Halozyme Therapeutics (HALO)Vaxcyte (PCVX)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Tesla (TSLA)Space Exploration Technologies (SPCX)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on LENZ
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 19, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.